Journal of Angiotherapy
Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
RESEARCH ARTICLE   (Open Access)
Contents Vol 8 (12)

Advances in Human Umbilical Vein Scaffolds for Vascular Tissue Engineering: Innovations, Challenges, and Future Directions

Thomas Jatiman 1*, Danang Himawan Limanto 1, Yan E Sembiring 1

+ Author Affiliations

Journal of Angiotherapy 8 (12) 1-8 https://doi.org/10.25163/angiotherapy.81210114

Submitted: 05 November 2024 Revised: 19 December 2024  Published: 20 December 2024 

Abstract

Tissue engineering and regenerative medicine have emerged as promising approaches for developing vascular grafts that mimic native blood vessels. The human umbilical vein (HUV) has been widely explored as a scaffold for vascular tissue engineering due to its biocompatibility, biodegradability, and ability to support endothelialization. This review explores the latest advancements in scaffold fabrication, including decellularization techniques, heparin modifications, and bioprinting strategies to enhance mechanical properties and endothelial cell adhesion. Induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) have shown potential in promoting vascularization and graft integration. Additionally, the role of extracellular matrix (ECM) remodeling and angiogenic factors in vascular graft performance is highlighted. Recent studies underscore the importance of hemodynamic factors in preventing intimal hyperplasia, a major challenge in graft longevity. Furthermore, vitrified umbilical arteries and tissue-engineered small-caliber grafts are being explored as alternatives for cardiovascular applications. This review provides insights into current strategies and future directions in vascular graft development, emphasizing precision personalized medicine approaches to optimize graft functionality and patient-specific therapies.

Keywords: Human umbilical vein, tissue engineering, vascular grafts, endothelialization, regenerative medicine

References

Caracciolo, P. C., Diaz-Rodriguez, P., Ardao, I., Moreira, D., Montini-Ballarin, F., Abraham, G. A., et al. (2021). Evaluation of human umbilical vein endothelial cells growth onto heparin-modified electrospun vascular grafts. International Journal of Biological Macromolecules, 179, 567–575.

Chan, B. P., & Leong, K. W. (2008). Scaffolding in tissue engineering: General approaches and tissue-specific considerations. European Spine Journal, 17(Suppl 4), 467. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587658/

Chen, G. H., Yang, J. G., Xia, H. F., Zhang, L. Z., Chen, Y. H., Wang, K. M., et al. (2022). Endothelial cells induce degradation of ECM through enhanced secretion of MMP14 carried on extracellular vesicles in venous malformation. Cell and Tissue Research, 389(3), 517–530. Retrieved from https://pubmed.ncbi.nlm.nih.gov/35786766/

Chen, J., Zhang, D., Wu, L.-P., & Zhao, M. (2023). Current Strategies for Engineered Vascular Grafts and Vascularized Tissue Engineering. Polymers, 15(9), 2015. https://doi.org/10.3390/polym15092015

Costa-Almeida, R., Granja, P. L., Soares, R., & Guerreiro, S. G. (2014). Cellular strategies to promote vascularisation in tissue engineering applications. European Cells & Materials, 28, 51–67.

Daniel, J., Abe, K., & McFetridge, P. S. (2005). Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO Journal, 51(3), 252–261.

Daniel, J., Abe, K., & McFetridge, P. S. (2005). Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO Journal, 51(3), 252–261.

Fazal, F., Raghav, S., Callanan, A., Koutsos, V., & Radacsi, N. (2021). Recent advancements in the bioprinting of vascular grafts. Biofabrication, 13(3).

Haruguchi, H., & Teraoka, S. (2003). Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. Journal of Artificial Organs, 6(4), 227–235. Retrieved from https://pubmed.ncbi.nlm.nih.gov/14691664/

Hoenicka, M., Jacobs, V. R., Huber, G., Schmid, F. X., & Birnbaum, D. E. (2008). Advantages of human umbilical vein scaffolds derived from cesarean section vs. vaginal delivery for vascular tissue engineering. Biomaterials, 29(8), 1075–1084.

Hoenicka, M., Lehle, K., Jacobs, V. R., Schmid, F. X., & Birnbaum, D. E. (2007). Properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft. Tissue Engineering, 219–229.

Hoenicka, M., Schrammel, S., Bursa, J., Huber, G., Bronger, H., Schmid, C., et al. (2013). Development of endothelium-denuded human umbilical veins as living scaffolds for tissue-engineered small-calibre vascular grafts. Journal of Tissue Engineering and Regenerative Medicine, 7(4), 324–336.

Hoenicka, M., Schrammel, S., Niemeyer, M., Huber, G., Schmid, C., & Birnbaum, D. E. (2010). Developing human umbilical vein as living scaffolds for vascular tissue engineering. IFMBE Proceedings, 31, 135–138.

Jia, H., Caputo, M., & Ghorbel, M. T. (2013). Stem cells in vascular graft tissue engineering for congenital heart surgery. Interventional Cardiology (London), 5(6), 647–662.

Kubis, N., & Levy, B. I. (2003). Vasculogenesis and angiogenesis: Molecular and cellular controls—Part 1: Growth factors. Interventional Neuroradiology, 9(3), 227. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548208/

Luo, J., Qin, L., Zhao, L., Gui, L., Ellis, M. W., Huang, Y., et al. (2020). Tissue-engineered vascular grafts with advanced mechanical strength from human iPSCs. Cell Stem Cell, 26(2), 251-261.e8.

Mallis, P., Katsimpoulas, M., Kostakis, A., Dipresa, D., Korossis, S., Papapanagiotou, A., et al. (2020). Vitrified human umbilical arteries as potential grafts for vascular tissue engineering. Tissue Engineering and Regenerative Medicine, 17(3), 285. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260347/

Mangold, S., Schrammel, S., Huber, G., Niemeyer, M., Schmid, C., Stangassinger, M., et al. (2015). Evaluation of decellularized human umbilical vein (HUV) for vascular tissue engineering—Comparison with endothelium-denuded HUV. Journal of Tissue Engineering and Regenerative Medicine, 9(1), 13–23.

Masson-Meyers, D. S., & Tayebi, L. (2021). Vascularization strategies in tissue engineering approaches for soft tissue repair. Journal of Tissue Engineering and Regenerative Medicine, 15, 747–762.

Meng, X., Xing, Y., Li, J., Deng, C., Li, Y., Ren, X., et al. (2021). Rebuilding the vascular network: In vivo and in vitro approaches. Frontiers in Cell and Developmental Biology, 9, 639299.

National Institute of Biomedical Imaging and Bioengineering. (n.d.). Tissue engineering and regenerative medicine. Retrieved from https://www.nibib.nih.gov/science-education/science-topics/tissue-engineering-and-regenerative-medicine

Olson, J. L., Atala, A., & Yoo, J. J. (2011). Tissue engineering: Current strategies and future directions. Chonnam Medical Journal, 47(1), 1. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214857/

Pashneh-Tala, S., MacNeil, S., & Claeyssens, F. (2016). The tissue-engineered vascular graft—Past, present, and future. Tissue Engineering Part B: Reviews, 22(1), 68. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753638/

Schultz, G. S., Chin, G. A., Moldawer, L., & Diegelmann, R. F. (2011). Principles of wound healing. Diabetic Foot Problems. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK534261/

Serbo, J. V., & Gerecht, S. (2013). Vascular tissue engineering: Biodegradable scaffold platforms to promote angiogenesis. Stem Cell Research & Therapy, 4(1), 1–8.

Thottappillil, N., & Nair, P. D. (2015). Scaffolds in vascular regeneration: Current status. Vascular Health and Risk Management, 11, 79–91.

Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
18
View
0
Share